AL amyloidosis (amyloid light chain or primary amyloidosis) is one type of the rare disorder amyloidosis. It happens when abnormal light chain proteins build up in your heart, kidneys and other organs. Healthcare providers treat it with medications that target the abnormal plasma cells. Some people may have a stem cell transplant.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
AL amyloidosis (amyloid light chain or primary amyloidosis) is a rare disease that can damage your heart, kidneys and other parts of your body. It’s the most common type of amyloidosis, which develops when plasma cells in your bone marrow change (mutate).
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The changed plasma cells make abnormal proteins called light chains. Unlike many blood cancers, this group of cells usually grows slowly. The abnormal proteins become twisted clumps that build up in your organs and tissues and keep them from working as they should.
Males are more likely to have this disease. It typically affects people age 60 and older. Early diagnosis and treatment can turn AL amyloidosis into a chronic disease. Without treatment, it can lead to life-threatening organ damage.
This disease can affect several areas of your body and cause different symptoms. AL amyloidosis typically affects your heart and/or kidneys. But it can affect your stomach, intestines, nerves and skin. Specific symptoms include:
This disease starts when a single plasma cell changes and makes copies of itself. The copies all make the same abnormal light chain protein. Experts don’t know why this happens.
Advertisement
A healthcare provider will do a physical exam and ask about your symptoms. AL amyloidosis can cause symptoms that resemble many diseases. Your provider may do several tests to narrow down possible causes. Tests may include:
Your provider may do biopsies to take tissue from your bone marrow, heart, kidneys or fat pads. A medical pathologist will use a special stain to check for amyloid deposits and confirm which type of amyloidosis you have. This step matters because each type needs different treatment.
Your treatment may be a combination of medications that destroy abnormal plasma cells. This puts the brakes on light chain protein buildup in your organs. The most common first treatment combines a targeted immunotherapy medication (daratumumab) with chemotherapy and a steroid.
This disease may damage your heart or kidneys, among other organs. You may need treatment to manage issues like congestive heart failure, kidney issues or neuropathy.
Some people may have an autologous stem cell transplant. For this procedure, you receive high-dose chemotherapy to destroy the abnormal plasma cells. Then, your own healthy stem cells are returned to you to rebuild your bone marrow.
Researchers are now investigating several new potential treatments for AL amyloidosis:
Talk to a provider right away if you have:
Contact them if the following symptoms last more than two weeks:
Advertisement
These are general symptoms that AL amyloidosis and many other diseases may cause. Talking to a provider is the first step toward understanding what’s going on in your body.
AL amyloidosis can damage your heart. Call 911 right away if you have:
For some people, AL amyloidosis is a long-term or chronic disease they can manage with medication. Even so, a chronic disease comes with its own set of medical challenges. You may need ongoing medical care for the issues AL amyloidosis can cause. You'll have regular checkups and tests. Ask your healthcare team to explain how the disease may affect your health in the long run.
Newer treatments are helping people live longer with AL amyloidosis. One study found many people now live five to 10 years or more after their diagnosis. That includes some people whose hearts were seriously affected when the disease was found.
AL amyloidosis is rare, which makes it hard for experts to estimate life expectancy. And everyone’s situation is a bit different. How long you’ll live with this disease may depend on factors like:
Advertisement
Your healthcare provider is your best source of information on your outlook and life expectancy.
There are several types of amyloidosis. Each type is named for the abnormal protein that causes the disease. In AL amyloidosis, “A” stands for amyloid and “L” stands for light chain, the abnormal protein that builds up and causes the disorder.
Other common amyloidosis types are serum amyloid A protein (AA amyloidosis) and ATTR (transthyretin) amyloidosis.
With AL amyloidosis, you may suspect that something is going on with your body, but you can’t pinpoint the problem. For example, there’s no obvious connection between bubbles in your pee and a pins-and-needles sensation in your hands. It may take time before healthcare providers can connect the dots to identify AL amyloidosis as the cause.
This disease can cause life-threatening organ damage. But thanks to newer treatments, many people manage AL amyloidosis as a long-term disease. And researchers are focused on new ways to treat it.
There are challenges to living with a chronic disease. Your care team will be there to help you manage them.
Advertisement
Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more.
Learn more about the Health Library and our editorial process.
Cleveland Clinic’s health articles are based on evidence-backed information and review by medical professionals to ensure accuracy, reliability and up-to-date clinical standards.
Cleveland Clinic’s health articles are based on evidence-backed information and review by medical professionals to ensure accuracy, reliability and up-to-date clinical standards.
When your body’s proteins clump together and affect your organs, Cleveland Clinic is here to help. We diagnose and treat all types of amyloidosis.
